Extendicare (TSE:EXE) Stock Price Crosses Above Two Hundred Day Moving Average – Time to Sell?

Extendicare Inc. (TSE:EXEGet Free Report)’s share price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of C$10.88 and traded as high as C$13.30. Extendicare shares last traded at C$13.24, with a volume of 92,658 shares.

Analysts Set New Price Targets

EXE has been the subject of several recent analyst reports. Cormark raised Extendicare to a “moderate buy” rating in a report on Wednesday, February 19th. TD Securities lifted their target price on Extendicare from C$10.50 to C$13.00 and gave the stock a “hold” rating in a research note on Monday, March 3rd. Finally, BMO Capital Markets increased their price target on shares of Extendicare from C$11.00 to C$13.50 in a research report on Monday, March 3rd.

Get Our Latest Stock Report on EXE

Extendicare Price Performance

The business has a 50-day moving average price of C$12.59 and a 200 day moving average price of C$10.91. The stock has a market cap of C$1.11 billion, a PE ratio of 16.88 and a beta of 1.26. The company has a current ratio of 0.62, a quick ratio of 0.98 and a debt-to-equity ratio of 283.02.

Extendicare Increases Dividend

The firm also recently declared a monthly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Thursday, May 15th will be given a $0.042 dividend. The ex-dividend date of this dividend is Wednesday, April 30th. This represents a $0.50 annualized dividend and a dividend yield of 3.81%. This is a positive change from Extendicare’s previous monthly dividend of $0.04. Extendicare’s payout ratio is 61.20%.

Extendicare Company Profile

(Get Free Report)

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.

Further Reading

Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.